Metabolism and Disease Flashcards

1
Q

metabolism at organism level

A
  • role and structure of specific tissues and organs
  • flux of metabolites from organ to organ
  • hormonal regulation of metabolism
  • control of body mass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

major endocrine glands

A
  • Brain: hypothalmus, pituitary
  • Thyroid, parathyroid
  • Adipose (fat) tissue
  • Adrenals (on top of the kidneys)
  • Pancreas
  • Ovaries/Testes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

hormones and target tissues

A

Signals originating in the central nervous system (top) pass via a series of relays to the ultimate target tissues (bottom). In addition to the systems shown, the thymus, pineal gland, and groups of cells in the gastrointestinal tract secrete hormones. Dashed lines represent neuronal connections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

top down vs bottom up signalling

A

Top down: Some signals originate in the brain, and the signal is sent out to the body.
o examples: oxytocin, vasopressin, cortisol (eg above diagram)

Bottom up: Some signals originate from elsewhere in the body and send messages to the brain.
o examples: epinepherine (adrenaline), insulin, leptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

bottom up signalling

A
  • requires tissue-specific responses to fuel
  • Regulation of feeding behavior by two-way information flow between tissues and the hypothalamus. When food intake and energy production are adequate, peptide hormones released by the stomach, intestine, and adipose tissue feed back on the hypothalamus to signal satiety and reduce feeding behaviour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

example of bottom up: liver

A
  • The portal vein carries nutrients to the liver.
  • Hepatocytes turn nutrients into fuel.
  • Hepatocyte enzymes turn over quickly.
  • Enzymes increase or decrease with changes in diet and the needs of other tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

summary of fuel movement during starvation

A
  • Initially liver glycogen –> glucose
  • Then gluconeogenesis is required. The liver needs substrates from other tissues.
  • Ie glycogenic amino acids mostly from the muscle
  • After a few days of fasting most of the energy requirements of the the body are met by fat catabolism = glucose sparing mechanism
  • Remainder is supplied by glycogenic amino acids
  • The brain adapts to using ketones

draw diagram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ketosis in starvation

A
  • Liver makes inc Acteyl CoA when fat is mobilised & glucose is dec.
  • inc Acteyl CoA normally -> TAG synthesis but if glucose is dec –> dec TAG
  • Therefore excess Acteyl CoA –> ketones –> acidosis in starvation
  • The liver maintains glucose output the amino acids for gluconeogenesis come from muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

forms of diabetes mellitus

A

Type 1: insufficient production of insulin

  • usually due to autoimmune destruction of B cells
  • usually develops early in life
  • used to be called insulin-dependent or juvenile diabetes

Type 2: insulin resistance

  • usually develops in late adulthood
  • usually associated with obesity
  • cells don’t respond appropriately to insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

diabetes symptoms

A
  • In both forms of diabetes, blood sugar becomes elevated.
    o The body tries to dilute the glucose, leading to excessive urination and thirst.
  • In Type 1, fat breakdown is accelerated, which leads to high production of ketone bodies.
    o Some of the ketones are ketoacids, which raise blood [H+], leading to ketoacidosis.
    o The bicarbonate buffering system is activated, leading to altered breathing
    o The breakdown of ketone body acetoacetate produces acetone, which is expelled via the breath
    o Untreated diabetes leads to dramatic weight loss.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

physiological effects of BGL

A
  • Random blood glucose >11.1mmol/L - abnormal
  • Blood glucose is normally determined after several hours of fasting. (<5.6mmol/L normal)
  • A high fasting blood glucose level (5.6 to 6.9 mmol/L) is a warning sign for diabetes (pre-diabetic).
  • > 7mmol/L indicates Diabetes – requires glucose tolerance test for definitive diagnosis
  • A low blood glucose level below 4mmol/L considered hypoglycemic in diabetics.
  • Blood glucose levels after a meal (postprandial) are typically higher (up to 145 mg/100 mL is normal).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

long-term effects of elevated BGL

A
  • Proteins can be glycosylated, especially at free amino groups.
  • Hemoglobin is abundant, has many exposed amino groups during formation, and entry of glucose into erythrocytes is not regulated.
    o hence, Hb easily glycosylated
    o compromises O2 delivery, especially in extremities
  • Blood test A1C between 5.7 and 6.4 percent indicates pre-diabetes
  • It increases the risk of cardiovascular disease, renal failure, and damage to small blood vessels and nerves.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

metabolic syndrome

A
Metabolic Syndrome is not a disease, but is a cluster of disorders of metabolism, including:
o High blood pressure
o elevated insulin levels
o Obesity (waist circumference) 
o Abnormal cholesterol levels
  • Each of these disorders is by itself a risk factor for other diseases.
  • In combination, these disorders dramatically boost the chances of developing potentially life-threatening illnesses, such as diabetes, heart disease or stroke.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

obesity

A
  • Metabolic Syndrome largely linked to obesity
  • Obesity is largely an energy storage issue
  • Regulated by hormones
  • Complex regulation influenced by:
    o appetite and eating behaviour
    o Exercise
    o Metabolic processing of fuel
  • Fat stored in the adipose tissue.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

adipose tissue releases adipokines

A
  • Adipose tissue is also an endocrine organ.
  • It releases peptide hormones called adipokines.
  • Adipokines carry information about fuel stores to brain
  • 2 key adipokines include leptin & adiponectin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

adiponectin

A
  • made by adipose tissue and has receptors in the brain
  • It circulates and makes other organs sensitive to insulin.
  • appears to work via AMP-activated kinase pathway.
  • AMPK phosphorylates and inactivates acetyl-CoA carboxylase.
    o Enzyme normally makes malonyl-CoA: Malonyl-CoA inhibits fatty acid import into mitochondria.
    o Reduced acetyl-CoA carboxylase means that fatty acids are free to enter the mitochondria for oxidation.
  • AMPK pathway also inhibits cholesterol synthesis.
  • Example of bottom up
17
Q

formation of adiponecting and its actions through AMPK

A

Fasting –>adipose tissue secretes and releases

adiponectin –> stim release of

AMPK – effects green and red arrows –> hungry

18
Q

leptin

A
  • Appetite suppressant
  • Sent from adipose tissue to the brain - reduces appetite
  • When the mass of adipose tissue increases (dashed outline), released leptin inhibits feeding and fat synthesis and stimulates oxidation of fatty acids. When the mass of adipose tissue decreases (solid outline), lowered leptin production favors greater food intake and less fatty acid oxidation.
19
Q

defects in leptin receptor

A
  • Also leads to obesity
  • The DB gene encodes the leptin receptor in the brain.
    o senses leptin sent from adipose tissue
  • db/db (homozygous) mice were obese and diabetic.
    o expressed mostly in the hypothalamus
    o associated with eating behavior
20
Q

affect on appetite-related hormones

A
Neuropeptide Y (NPY) is an appetite-stimulating (orexigenic) hormone.
o sends signal to eat
o levels rise in starvation
o levels rise in ob/ob and db/db mice
o inhibited by leptin and insulin
  • a-melanocyte-stimulating hormone (a-MSH) is an appetite-suppressing (anorexigenic) hormone.
    o sends signal to stop eating
    o release stimulated by leptin

Orexigenic - appetite-stimulating
Anorexigenic - appetite-suppressing

21
Q

hypothalamic regulation of food intake and energy expenditure

A

Role of the hypothalamus in its interaction with adipose tissue. The hypothalamus receives input (leptin) from adipose tissue and responds with neuronal signals to adipocytes.

This signal (norepinephrine) activates protein kinase A, which triggers mobilization of fatty acids from TAG and their uncoupled oxidation in mitochondria, generating heat but not ATP. DAG, diacylglycerol; MAG, monoacylglycerol.

22
Q

effects of leptin on adipose tissue

A
  • Releases Hormones from Adipose Tissue:
    o Inhibits Neuropeptide Y (NPY): Switches off appetite
    o Increases a-melanocyte-stimulating hormone (a-MSH): Suppresses appetite
  • Stimulates Hypothalamus to release Norepinephrine:
    o Stimulates transcription of UCP1 gene: Uncouples ETC – release heat without ATP and Breaks down TAGs and releases Fatty Acids
  • Leptin increases transcription of gene yielding a-MSH
23
Q

leptin increases thermogenesis

A

via SNS
- Neurons in the hypothalmus send signals to adipose tissue and so on.
- It stimulates release of norepinephrine.
- A cascade via B3-adrenergic receptors increases transcription of UCP1 gene.
- It increases thermogenesis –> Energy from the H+ gradient in mitochondria is released as heat without making ATP.
o increased fat loss to compensate

24
Q

leptin resistance in obesity

A
  • Restoring leptin to ob/ob mice results in restoration to normal body mass.
  • BUT, leptin administration to most obese people does NOT restore normal body mass.
    o This was a great disappointment to the pharmaceutical industry.
    o Leptin is in fact elevated in many cases of obesity.
  • Something downstream in leptin response must be defective (“leptin resistance”).
25
Q

insulin as an appetite inhibitor

A
  • Via interaction with hypothalamus
  • The orexigenic neurons have insulin receptors.
  • Insulin binding:
    o inhibits release of appetite-stimulating NPY
    o stimulates appetite-suppressing a-MSH
  • There may be cross-talk between insulin and leptin pathways!
    o Leptin makes liver and muscle more sensitive to insulin.
    o A common 2º messenger may enable leptin and insulin to trigger the same downstream pathways.
26
Q

PPARs alter gene expression for fat and CHO metabolism

A

Peroxisome Proliferator−Activated Receptors

  • Bind fatty acids or derivatives
  • Signal that you are full
27
Q

Gherkin

A
  • Short-term orexigenic peptide secreted in the stomach
  • Ghrelin receptors appear in the brain, the heart, and adipose tissue.
  • It works via G protein−coupled receptors to increase the sensation of hunger.
  • Injections of ghrelin immediately increase appetite.
  • Prader-Willi syndrome is associated with high levels of ghrelin and insatiable appetite.
28
Q

PYY 3-36 hormone

A

Secreted from the Small Intestine and Colon

  • PYY3-36 is an Appetite-Suppressing hormone
  • Secreted in response to food entering stomach
  • Transported to hypothalmus
  • Inhibits release of orexigenic NPY
  • Result is reduced hunger
29
Q

microbes in gut influence on obesity

A
  • Obese and lean persons have different gut microbial flora.
  • Some microorganisms create fermentation products that affect adipose tissue.
    o Most products are short-chain FA: acetate propionate, butyrate, and so on.
    o Propionate is known to act on GPCRs of precursor cells, inducing them to become adipocytes and inhibiting lipolysis
30
Q

T2 diabetes and metabolic syndrome

A

Cluster of symptoms along with insulin resistance:
o abdominal obesity
o high triglycerides (TAGs)
o low HDL
o high blood pressure
o elevated blood glucose (pre-diabetic)
o often includes other signs of inflammation

31
Q

“lipid burden” hypotheis

A
  • explain path from obesity to T2 Diabetes
  • 80% of type 2 diabetics are obese, but not all obese individuals develop diabetes.
  • Adipocytes become packed and unable to accommodate more TAG.
  • The inability to deposit TAG leads to FA in the blood.
  • Excess FA enter muscle and the liver, create TAG lipid droplets, and cause these organs to lose sensitivity to insulin –> Ultimately, blood glucose levels rise.
  • Energy equation: Ein > Eout = weight gain
32
Q

overloading adipocytes

A

Lean: TAG diet = TAG catabolised

Overweight: TAG diet > TAG
catabolised

Pro-inflammatory: enlarged adipocyte produce MCP-1

Chronic inflammation: macrophages infiltrate adipose tissue

33
Q

treatment for T2 diabetes

A
  • Diet and exercise to reduce obesity, manage blood glucose, increase insulin sensitivity of muscles
  • Insulin, if endogenous insulin secretion is inadequate
  • AMPK activator: Metformin (glucophage)
  • PPAR activators to increase adiponectin, stimulate adipocyte differential, and increase capacity for TAG storage: thiozidinediones
  • Stimulation of insulin by binding to ATP-gated K+ channels: sulfonylureas
  • Preventing proteolytic degradation of glucagon-like peptide-1 (GLP-1), a peptide that stimulates insulin secretion (dipeptidyl protease-4 inhibitors such as Januvia)